Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
NG2 GAD
print preview
bookmark
share with colleague
General Information
Company
Diamyd Medical AB
Description
Glutamic acid decarboxylase (GAD) gene delivered directly to nerve cells using NTDDS (nerve targeting drug delivery system)
Molecular Target
Mechanism of Action
Gene therapy
Latest Stage of Development
Preclinical
Indication
Pain
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy